ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Japan to donate 1m COVID vaccine doses to Vietnam on Wednesday

Jabs for Indonesia, Thailand, Philippines and Malaysia considered in July

Japan has secured enough AstraZeneca vaccine doses for 60 million people but does not intend to use them immediately in domestic inoculation programs.   © Reuters

TOKYO (Kyodo) -- Japan will donate 1 million coronavirus vaccine doses to Vietnam on Wednesday, Japanese Foreign Minister Toshimitsu Motegi said.

Tokyo is also mulling donating amounts of COVID-19 vaccine to Indonesia, Malaysia, the Philippines and Thailand in July, Motegi said in a news conference on Tuesday.

"After considering comprehensively the infection situation (in Vietnam), the shortage of vaccines and relationship with Japan, we have come to that decision," Motegi said.

The provision of the vaccine developed by Britain's AstraZeneca and produced under license in Japan came in response to a request from Vietnam. It follows Japan's donation of 1.24 million shots to Taiwan earlier in the month. Vietnam has been facing a resurgence of infections since April, with its health authorities reporting a hybrid coronavirus variant that combines characteristics of strains first detected in Britain and India.

While Japan has secured enough AstraZeneca vaccine doses for 60 million people and approved their use last month, it does not intend to use them immediately in public inoculation programs due to rare cases of blood clots reported overseas.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more